
AdvisorShares Pure US Cannabis ETF
ETF · USD
Price
$3.85
Cap
$790M
Earnings
—
30d Trend
+5%
Lower half of range — may offer entry value
Key macro factors
Federal Cannabis Rescheduling/Legalization: Potential rescheduling from Schedule I to Schedule III under federal law could alleviate significant tax burdens (Section 280E) and improve banking access for cannabis companies, directly boosting the profitability and valuations of MSOS's holdings.
State-level Adult-Use Ballot Measures/Expansion: Continued expansion of legal cannabis markets through state-level adult-use ballot measures (e.g., Florida, Pennsylvania) will expand the addressable market for multi-state operators, directly impacting the revenue and growth potential of companies within the MSOS ETF.
Inflationary Pressures & Oversupply: Persistent oversupply in fragmented state markets and ongoing inflationary pressures on cultivation and operational costs can negatively impact the profit margins and overall financial health of cannabis companies, posing a challenge for the ETF.
MSOS is an actively managed narrow portfolio of US stocks or swap contracts related to the domestic cannabis and hemp industry.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
